Segment disclosures

Company overview

VIATRIS INC.

Each reported dimension combination stays separate. Revenue and operating income are shown as reported, with their dates and sources.

Revenue · Reported segment facts

36 dimension combinations 758 retained observations 26 reported periods Partial retained history

Counts describe retained dimensioned rows only. Periods and members can change across reports, and this view does not infer missing values or expected segment totals.

Operating Segments · Developed Markets Segment

Consolidation Items · Statement Business Segments

Source dimensions srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=vtrs:DevelopedMarketsSegmentMember
PeriodValueUnitFiledEvidence
2026-04-01 – 2026-06-302193700000 USD20260806Open filing evidence
2026-01-01 – 2026-06-304214500000 USD20260806Open filing evidence
2026-01-01 – 2026-03-312020800000 USD20260507Open filing evidence
2025-01-01 – 2025-12-318552100000 RestatedUSD20260226Open filing evidence
2025-07-01 – 2025-09-302255600000 USD20251106Open filing evidence
2025-01-01 – 2025-09-306266600000 USD20251106Open filing evidence
2025-04-01 – 2025-06-302119300000 USD20260806Open filing evidence
2025-01-01 – 2025-06-304011000000 USD20260806Open filing evidence
2025-01-01 – 2025-03-311891700000 USD20260507Open filing evidence
2024-01-01 – 2024-12-318961400000 RestatedUSD20260226Open filing evidence
2024-07-01 – 2024-09-302298700000 USD20251106Open filing evidence
2024-01-01 – 2024-09-306783300000 USD20251106Open filing evidence
2024-04-01 – 2024-06-302319200000 USD20250807Open filing evidence
2024-01-01 – 2024-06-304484600000 USD20250807Open filing evidence
2024-01-01 – 2024-03-312165400000 USD20250508Open filing evidence
2023-01-01 – 2023-12-319278000000 RestatedUSD20260226Open filing evidence
2023-07-01 – 2023-09-302408500000 USD20241107Open filing evidence
2023-01-01 – 2023-09-306932700000 USD20241107Open filing evidence
2023-04-01 – 2023-06-302353800000 USD20240808Open filing evidence
2023-01-01 – 2023-06-304524200000 USD20240808Open filing evidence
2023-01-01 – 2023-03-312170400000 USD20240509Open filing evidence
2022-01-01 – 2022-12-319790700000 RestatedUSD20250227Open filing evidence
2022-07-01 – 2022-09-302431500000 USD20231108Open filing evidence
2022-01-01 – 2022-09-307386700000 USD20231108Open filing evidence
2022-04-01 – 2022-06-302479100000 USD20220808Open filing evidence
2022-01-01 – 2022-06-304955200000 USD20220808Open filing evidence
2022-01-01 – 2022-03-312476100000 USD20230508Open filing evidence
2021-01-01 – 2021-12-3110428700000 USD20240228Open filing evidence
2021-04-01 – 2021-06-302640400000 USD20220808Open filing evidence
2021-01-01 – 2021-06-305212000000 USD20220808Open filing evidence
2021-01-01 – 2021-03-312571600000 USD20220509Open filing evidence
2020-01-01 – 2020-12-318510900000 USD20230227Open filing evidence
2020-04-01 – 2020-06-301982700000 USD20210809Open filing evidence
2020-01-01 – 2020-06-303969100000 USD20210809Open filing evidence

Operating Segments · Emerging Markets Segment

Consolidation Items · Statement Business Segments

Source dimensions srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=vtrs:EmergingMarketsSegmentMember
PeriodValueUnitFiledEvidence
2026-04-01 – 2026-06-30542300000 USD20260806Open filing evidence
2026-01-01 – 2026-06-301077700000 USD20260806Open filing evidence
2026-01-01 – 2026-03-31535400000 USD20260507Open filing evidence
2025-01-01 – 2025-12-312217600000 RestatedUSD20260226Open filing evidence
2025-07-01 – 2025-09-30570400000 USD20251106Open filing evidence
2025-01-01 – 2025-09-301645400000 USD20251106Open filing evidence
2025-04-01 – 2025-06-30555100000 USD20260806Open filing evidence
2025-01-01 – 2025-06-301075000000 USD20260806Open filing evidence
2025-01-01 – 2025-03-31519900000 USD20260507Open filing evidence
2024-01-01 – 2024-12-312260400000 RestatedUSD20260226Open filing evidence
2024-07-01 – 2024-09-30533200000 USD20251106Open filing evidence
2024-01-01 – 2024-09-301737700000 USD20251106Open filing evidence
2024-04-01 – 2024-06-30578100000 USD20250807Open filing evidence
2024-01-01 – 2024-06-301204500000 USD20250807Open filing evidence
2024-01-01 – 2024-03-31626400000 USD20250508Open filing evidence
2023-01-01 – 2023-12-312562900000 RestatedUSD20260226Open filing evidence
2023-07-01 – 2023-09-30642500000 USD20241107Open filing evidence
2023-01-01 – 2023-09-301932500000 USD20241107Open filing evidence
2023-04-01 – 2023-06-30648100000 USD20240808Open filing evidence
2023-01-01 – 2023-06-301290000000 USD20240808Open filing evidence
2023-01-01 – 2023-03-31641900000 USD20230508Open filing evidence
2022-01-01 – 2022-12-312637000000 RestatedUSD20250227Open filing evidence
2022-07-01 – 2022-09-30678900000 USD20231108Open filing evidence
2022-01-01 – 2022-09-302035000000 USD20231108Open filing evidence
2022-04-01 – 2022-06-30650900000 USD20220808Open filing evidence
2022-01-01 – 2022-06-301356100000 USD20220808Open filing evidence
2022-01-01 – 2022-03-31705200000 USD20230508Open filing evidence
2021-01-01 – 2021-12-313144700000 USD20240228Open filing evidence
2021-07-01 – 2021-09-30792500000 USD20221107Open filing evidence
2021-01-01 – 2021-09-302417200000 USD20221107Open filing evidence
2021-04-01 – 2021-06-30870000000 USD20220808Open filing evidence
2021-01-01 – 2021-06-301624700000 USD20220808Open filing evidence
2020-01-01 – 2020-12-311853800000 USD20220228Open filing evidence

Operating Segments · Greater China Segment

Consolidation Items · Statement Business Segments

Source dimensions srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=vtrs:GreaterChinaSegmentMember
PeriodValueUnitFiledEvidence
2026-04-01 – 2026-06-30713800000 USD20260806Open filing evidence
2026-01-01 – 2026-06-301393900000 USD20260806Open filing evidence
2026-01-01 – 2026-03-31680100000 USD20260507Open filing evidence
2025-01-01 – 2025-12-312332500000 USD20260226Open filing evidence
2025-07-01 – 2025-09-30615200000 USD20251106Open filing evidence
2025-01-01 – 2025-09-301759600000 USD20251106Open filing evidence
2025-04-01 – 2025-06-30588900000 USD20260806Open filing evidence
2025-01-01 – 2025-06-301144400000 USD20260806Open filing evidence
2025-01-01 – 2025-03-31555500000 USD20260507Open filing evidence
2024-01-01 – 2024-12-312167800000 RestatedUSD20260226Open filing evidence
2024-07-01 – 2024-09-30561800000 USD20251106Open filing evidence
2024-01-01 – 2024-09-301644700000 USD20251106Open filing evidence
2024-04-01 – 2024-06-30539000000 USD20250807Open filing evidence
2024-01-01 – 2024-06-301082900000 USD20250807Open filing evidence
2024-01-01 – 2024-03-31543900000 USD20250508Open filing evidence
2023-01-01 – 2023-12-312160400000 USD20260226Open filing evidence
2023-07-01 – 2023-09-30548400000 USD20241107Open filing evidence
2023-01-01 – 2023-09-301645100000 USD20241107Open filing evidence
2023-04-01 – 2023-06-30532100000 USD20240808Open filing evidence
2023-01-01 – 2023-06-301096700000 USD20240808Open filing evidence
2023-01-01 – 2023-03-31564600000 USD20240509Open filing evidence
2022-01-01 – 2022-12-312201200000 USD20250227Open filing evidence
2022-07-01 – 2022-09-30574000000 USD20231108Open filing evidence
2022-01-01 – 2022-09-301695400000 USD20231108Open filing evidence
2022-04-01 – 2022-06-30548300000 USD20220808Open filing evidence
2022-01-01 – 2022-06-301121400000 USD20220808Open filing evidence
2022-01-01 – 2022-03-31573100000 USD20230508Open filing evidence
2021-01-01 – 2021-12-312212800000 USD20240228Open filing evidence
2021-07-01 – 2021-09-30566800000 USD20221107Open filing evidence
2021-01-01 – 2021-09-301709000000 USD20221107Open filing evidence
2021-04-01 – 2021-06-30550300000 USD20220808Open filing evidence
2021-01-01 – 2021-06-301142200000 USD20220808Open filing evidence
2021-01-01 – 2021-03-31591900000 USD20210510Open filing evidence
2020-01-01 – 2020-12-31259900000 USD20230227Open filing evidence

Operating Segments · Japan Australia And New Zealand Segment

Consolidation Items · Statement Business Segments

Source dimensions srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=vtrs:JapanAustraliaAndNewZealandSegmentMember
PeriodValueUnitFiledEvidence
2026-04-01 – 2026-06-30296100000 USD20260806Open filing evidence
2026-01-01 – 2026-06-30569500000 USD20260806Open filing evidence
2026-01-01 – 2026-03-31273400000 USD20260507Open filing evidence
2025-01-01 – 2025-12-311197700000 RestatedUSD20260226Open filing evidence
2025-07-01 – 2025-09-30306300000 USD20251106Open filing evidence
2025-01-01 – 2025-09-30888100000 USD20251106Open filing evidence
2025-04-01 – 2025-06-30305700000 USD20260806Open filing evidence
2025-01-01 – 2025-06-30581800000 USD20260806Open filing evidence
2025-01-01 – 2025-03-31276100000 USD20260507Open filing evidence
2024-01-01 – 2024-12-311349700000 RestatedUSD20260226Open filing evidence
2024-07-01 – 2024-09-30344300000 USD20251106Open filing evidence
2024-01-01 – 2024-09-301011700000 USD20251106Open filing evidence
2024-04-01 – 2024-06-30349600000 USD20250807Open filing evidence
2024-01-01 – 2024-06-30667400000 USD20250807Open filing evidence
2024-01-01 – 2024-03-31317800000 USD20250508Open filing evidence
2023-01-01 – 2023-12-311425600000 RestatedUSD20260226Open filing evidence
2023-07-01 – 2023-09-30334500000 USD20241107Open filing evidence
2023-01-01 – 2023-09-301052200000 USD20241107Open filing evidence
2023-04-01 – 2023-06-30375500000 USD20240808Open filing evidence
2023-01-01 – 2023-06-30717700000 USD20240808Open filing evidence
2022-01-01 – 2022-12-311633800000 RestatedUSD20250227Open filing evidence
2022-07-01 – 2022-09-30383000000 USD20231108Open filing evidence
2022-01-01 – 2022-09-301233900000 USD20231108Open filing evidence
2022-04-01 – 2022-06-30427100000 USD20220808Open filing evidence
2022-01-01 – 2022-06-30850900000 USD20220808Open filing evidence
2022-01-01 – 2022-03-31423800000 USD20220509Open filing evidence
2021-01-01 – 2021-12-312027400000 USD20230227Open filing evidence
2021-07-01 – 2021-09-30505300000 USD20221107Open filing evidence
2021-01-01 – 2021-09-301488200000 USD20221107Open filing evidence
2021-04-01 – 2021-06-30501000000 USD20220808Open filing evidence
2021-01-01 – 2021-06-30982900000 USD20220808Open filing evidence
2021-01-01 – 2021-03-31481900000 USD20220509Open filing evidence
2020-01-01 – 2020-12-311195300000 USD20230227Open filing evidence

Brands · Developed Markets Segment

Product Or Service · Statement Business Segments

Source dimensions srt:ProductOrServiceAxis=vtrs:BrandsMember;us-gaap:StatementBusinessSegmentsAxis=vtrs:DevelopedMarketsSegmentMember
PeriodValueUnitFiledEvidence
2026-04-01 – 2026-06-301122300000 USD20260806Open filing evidence
2026-01-01 – 2026-06-302191300000 USD20260806Open filing evidence
2026-01-01 – 2026-03-311069000000 USD20260507Open filing evidence
2025-01-01 – 2025-12-314571200000 USD20260226Open filing evidence
2025-07-01 – 2025-09-301241300000 USD20251106Open filing evidence
2025-01-01 – 2025-09-303382500000 USD20251106Open filing evidence
2025-04-01 – 2025-06-301121400000 USD20260806Open filing evidence
2025-01-01 – 2025-06-302141200000 USD20260806Open filing evidence
2025-01-01 – 2025-03-311019800000 USD20260507Open filing evidence
2024-01-01 – 2024-12-314731600000 USD20260226Open filing evidence
2024-07-01 – 2024-09-301217600000 USD20251106Open filing evidence
2024-01-01 – 2024-09-303630200000 USD20251106Open filing evidence
2024-04-01 – 2024-06-301233800000 USD20250807Open filing evidence
2024-01-01 – 2024-06-302412600000 USD20250807Open filing evidence
2024-01-01 – 2024-03-311178800000 USD20250508Open filing evidence
2023-01-01 – 2023-12-315239000000 USD20260226Open filing evidence
2023-07-01 – 2023-09-301391300000 USD20241107Open filing evidence
2023-01-01 – 2023-09-303923500000 USD20241107Open filing evidence
2023-04-01 – 2023-06-301300200000 USD20240808Open filing evidence
2023-01-01 – 2023-06-302532200000 USD20240808Open filing evidence
2023-01-01 – 2023-03-311232000000 USD20240509Open filing evidence
2022-01-01 – 2022-12-315160400000 USD20250227Open filing evidence
2022-04-01 – 2022-06-301305400000 USD20230807Open filing evidence
2022-01-01 – 2022-06-302604100000 USD20230807Open filing evidence
2021-01-01 – 2021-12-315759200000 USD20240228Open filing evidence
2021-04-01 – 2021-06-301424100000 USD20220808Open filing evidence
2021-01-01 – 2021-06-302827800000 USD20220808Open filing evidence
2021-01-01 – 2021-03-311403700000 USD20210510Open filing evidence
2020-01-01 – 2020-12-313920700000 USD20230227Open filing evidence
2020-04-01 – 2020-06-30855500000 USD20210809Open filing evidence
2020-01-01 – 2020-06-301747000000 USD20210809Open filing evidence

Brands · Emerging Markets Segment

Product Or Service · Statement Business Segments

Source dimensions srt:ProductOrServiceAxis=vtrs:BrandsMember;us-gaap:StatementBusinessSegmentsAxis=vtrs:EmergingMarketsSegmentMember
PeriodValueUnitFiledEvidence
2026-04-01 – 2026-06-30441200000 USD20260806Open filing evidence
2026-01-01 – 2026-06-30888400000 USD20260806Open filing evidence
2026-01-01 – 2026-03-31447200000 USD20260507Open filing evidence
2025-01-01 – 2025-12-311673600000 USD20260226Open filing evidence
2025-07-01 – 2025-09-30424100000 USD20251106Open filing evidence
2025-01-01 – 2025-09-301242700000 USD20251106Open filing evidence
2025-04-01 – 2025-06-30416100000 USD20260806Open filing evidence
2025-01-01 – 2025-06-30818600000 USD20260806Open filing evidence
2025-01-01 – 2025-03-31402500000 USD20260507Open filing evidence
2024-01-01 – 2024-12-311567800000 USD20260226Open filing evidence
2024-07-01 – 2024-09-30395900000 USD20251106Open filing evidence
2024-01-01 – 2024-09-301195500000 USD20251106Open filing evidence
2024-04-01 – 2024-06-30395200000 USD20250807Open filing evidence
2024-01-01 – 2024-06-30799600000 USD20250807Open filing evidence
2024-01-01 – 2024-03-31404400000 USD20250508Open filing evidence
2023-01-01 – 2023-12-311626500000 USD20260226Open filing evidence
2023-07-01 – 2023-09-30409600000 USD20241107Open filing evidence
2023-01-01 – 2023-09-301251800000 USD20241107Open filing evidence
2023-04-01 – 2023-06-30406600000 USD20240808Open filing evidence
2023-01-01 – 2023-06-30842200000 USD20240808Open filing evidence
2022-01-01 – 2022-12-311615900000 USD20250227Open filing evidence
2022-07-01 – 2022-09-30429100000 USD20221107Open filing evidence
2022-01-01 – 2022-09-301254100000 USD20221107Open filing evidence
2022-04-01 – 2022-06-30388300000 USD20230807Open filing evidence
2022-01-01 – 2022-06-30825000000 USD20230807Open filing evidence
2021-01-01 – 2021-12-311677200000 USD20240228Open filing evidence
2021-07-01 – 2021-09-30414500000 USD20221107Open filing evidence
2021-01-01 – 2021-09-301293500000 USD20221107Open filing evidence
2021-04-01 – 2021-06-30433000000 USD20220808Open filing evidence
2021-01-01 – 2021-06-30879000000 USD20220808Open filing evidence
2021-01-01 – 2021-03-31446000000 USD20210510Open filing evidence
2020-01-01 – 2020-12-31443300000 USD20230227Open filing evidence
2020-04-01 – 2020-06-3067400000 USD20210809Open filing evidence
2020-01-01 – 2020-06-30132100000 USD20210809Open filing evidence

Brands · Greater China Segment

Product Or Service · Statement Business Segments

Source dimensions srt:ProductOrServiceAxis=vtrs:BrandsMember;us-gaap:StatementBusinessSegmentsAxis=vtrs:GreaterChinaSegmentMember
PeriodValueUnitFiledEvidence
2026-04-01 – 2026-06-30710800000 USD20260806Open filing evidence
2026-01-01 – 2026-06-301388000000 USD20260806Open filing evidence
2026-01-01 – 2026-03-31677200000 USD20260507Open filing evidence
2025-01-01 – 2025-12-312321800000 USD20260226Open filing evidence
2025-07-01 – 2025-09-30612300000 USD20251106Open filing evidence
2025-01-01 – 2025-09-301751600000 USD20251106Open filing evidence
2025-04-01 – 2025-06-30586500000 USD20260806Open filing evidence
2025-01-01 – 2025-06-301139300000 USD20260806Open filing evidence
2025-01-01 – 2025-03-31552800000 USD20260507Open filing evidence
2024-01-01 – 2024-12-312156700000 USD20260226Open filing evidence
2024-07-01 – 2024-09-30559400000 USD20251106Open filing evidence
2024-01-01 – 2024-09-301636900000 USD20251106Open filing evidence
2024-04-01 – 2024-06-30535700000 USD20250807Open filing evidence
2024-01-01 – 2024-06-301077500000 USD20250807Open filing evidence
2024-01-01 – 2024-03-31541800000 USD20250508Open filing evidence
2023-01-01 – 2023-12-312152100000 USD20260226Open filing evidence
2023-07-01 – 2023-09-30546500000 USD20241107Open filing evidence
2023-01-01 – 2023-09-301639400000 USD20241107Open filing evidence
2023-04-01 – 2023-06-30530500000 USD20240808Open filing evidence
2023-01-01 – 2023-06-301092900000 USD20240808Open filing evidence
2023-01-01 – 2023-03-31562400000 USD20240509Open filing evidence
2022-01-01 – 2022-12-312190700000 USD20250227Open filing evidence
2022-07-01 – 2022-09-30571900000 USD20231108Open filing evidence
2022-01-01 – 2022-09-301687900000 USD20231108Open filing evidence
2022-04-01 – 2022-06-30546300000 USD20230807Open filing evidence
2022-01-01 – 2022-06-301116000000 USD20230807Open filing evidence
2022-01-01 – 2022-03-31569700000 USD20230508Open filing evidence
2021-01-01 – 2021-12-312207800000 USD20230227Open filing evidence
2021-04-01 – 2021-06-30549200000 USD20220808Open filing evidence
2021-01-01 – 2021-06-301140100000 USD20220808Open filing evidence
2021-01-01 – 2021-03-31590900000 USD20210510Open filing evidence
2020-01-01 – 2020-12-31253900000 USD20230227Open filing evidence
2020-04-01 – 2020-06-3022000000 USD20210809Open filing evidence
2020-01-01 – 2020-06-3036700000 USD20210809Open filing evidence

Brands · Japan Australia And New Zealand Segment

Product Or Service · Statement Business Segments

Source dimensions srt:ProductOrServiceAxis=vtrs:BrandsMember;us-gaap:StatementBusinessSegmentsAxis=vtrs:JapanAustraliaAndNewZealandSegmentMember
PeriodValueUnitFiledEvidence
2026-04-01 – 2026-06-30144100000 USD20260806Open filing evidence
2026-01-01 – 2026-06-30283200000 USD20260806Open filing evidence
2026-01-01 – 2026-03-31139100000 USD20260507Open filing evidence
2025-01-01 – 2025-12-31617400000 USD20260226Open filing evidence
2025-07-01 – 2025-09-30159100000 USD20251106Open filing evidence
2025-01-01 – 2025-09-30461400000 USD20251106Open filing evidence
2025-04-01 – 2025-06-30160500000 USD20260806Open filing evidence
2025-01-01 – 2025-06-30302300000 USD20260806Open filing evidence
2025-01-01 – 2025-03-31141800000 USD20260507Open filing evidence
2024-01-01 – 2024-12-31744200000 USD20260226Open filing evidence
2024-07-01 – 2024-09-30189300000 USD20251106Open filing evidence
2024-01-01 – 2024-09-30571800000 USD20251106Open filing evidence
2024-04-01 – 2024-06-30198400000 USD20250807Open filing evidence
2024-01-01 – 2024-06-30382500000 USD20250807Open filing evidence
2024-01-01 – 2024-03-31184100000 USD20250508Open filing evidence
2023-01-01 – 2023-12-31782900000 USD20260226Open filing evidence
2023-07-01 – 2023-09-30185700000 USD20241107Open filing evidence
2023-01-01 – 2023-09-30583400000 USD20241107Open filing evidence
2023-04-01 – 2023-06-30207400000 USD20240808Open filing evidence
2023-01-01 – 2023-06-30397700000 USD20240808Open filing evidence
2022-01-01 – 2022-12-31922600000 USD20250227Open filing evidence
2022-04-01 – 2022-06-30243100000 USD20230807Open filing evidence
2022-01-01 – 2022-06-30492100000 USD20230807Open filing evidence
2022-01-01 – 2022-03-31249000000 USD20220509Open filing evidence
2021-01-01 – 2021-12-311197100000 USD20230227Open filing evidence
2021-04-01 – 2021-06-30295400000 USD20220808Open filing evidence
2021-01-01 – 2021-06-30579400000 USD20220808Open filing evidence
2021-01-01 – 2021-03-31284000000 USD20220509Open filing evidence
2020-01-01 – 2020-12-31617000000 USD20230227Open filing evidence
2020-04-01 – 2020-06-30128100000 USD20210809Open filing evidence
2020-01-01 – 2020-06-30218700000 USD20210809Open filing evidence

Complex GX And Biosimilars · Developed Markets Segment

Product Or Service · Statement Business Segments

Source dimensions srt:ProductOrServiceAxis=vtrs:ComplexGXAndBiosimilarsMember;us-gaap:StatementBusinessSegmentsAxis=vtrs:DevelopedMarketsSegmentMember
PeriodValueUnitFiledEvidence
2023-07-01 – 2023-09-30166100000 USD20231108Open filing evidence
2023-01-01 – 2023-09-30428700000 USD20231108Open filing evidence
2023-01-01 – 2023-03-31129900000 USD20230508Open filing evidence
2022-01-01 – 2022-12-311218000000 USD20230227Open filing evidence
2022-07-01 – 2022-09-30295000000 USD20231108Open filing evidence
2022-01-01 – 2022-09-30986100000 USD20231108Open filing evidence
2022-01-01 – 2022-03-31364100000 USD20230508Open filing evidence
2021-01-01 – 2021-12-311241600000 USD20230227Open filing evidence
2021-07-01 – 2021-09-30305100000 USD20211108Open filing evidence
2021-01-01 – 2021-09-30926400000 USD20211108Open filing evidence
2021-04-01 – 2021-06-30309300000 USD20210809Open filing evidence
2021-01-01 – 2021-06-30621300000 USD20210809Open filing evidence
2021-01-01 – 2021-03-31312000000 USD20220509Open filing evidence
2020-01-01 – 2020-12-311202600000 USD20230227Open filing evidence
2020-07-01 – 2020-09-30325800000 USD20211108Open filing evidence
2020-01-01 – 2020-09-30896000000 USD20211108Open filing evidence
2020-04-01 – 2020-06-30328600000 USD20210809Open filing evidence
2020-01-01 – 2020-06-30570200000 USD20210809Open filing evidence

Complex GX And Biosimilars · Emerging Markets Segment

Product Or Service · Statement Business Segments

Source dimensions srt:ProductOrServiceAxis=vtrs:ComplexGXAndBiosimilarsMember;us-gaap:StatementBusinessSegmentsAxis=vtrs:EmergingMarketsSegmentMember
PeriodValueUnitFiledEvidence
2023-07-01 – 2023-09-30300000 USD20231108Open filing evidence
2023-01-01 – 2023-09-30400000 USD20231108Open filing evidence
2022-01-01 – 2022-12-3150700000 USD20230227Open filing evidence
2022-07-01 – 2022-09-3014100000 USD20231108Open filing evidence
2022-01-01 – 2022-09-3045900000 USD20231108Open filing evidence
2021-01-01 – 2021-12-3153800000 USD20230227Open filing evidence
2021-07-01 – 2021-09-3013700000 USD20221107Open filing evidence
2021-01-01 – 2021-09-3035400000 USD20221107Open filing evidence
2020-01-01 – 2020-12-3149400000 USD20230227Open filing evidence

Complex GX And Biosimilars · Greater China Segment

Product Or Service · Statement Business Segments

Source dimensions srt:ProductOrServiceAxis=vtrs:ComplexGXAndBiosimilarsMember;us-gaap:StatementBusinessSegmentsAxis=vtrs:GreaterChinaSegmentMember
PeriodValueUnitFiledEvidence
2023-07-01 – 2023-09-300 USD20231108Open filing evidence
2023-01-01 – 2023-09-300 USD20231108Open filing evidence
2023-01-01 – 2023-03-310 USD20230508Open filing evidence
2022-01-01 – 2022-12-31600000 USD20230227Open filing evidence
2022-07-01 – 2022-09-30200000 USD20231108Open filing evidence
2022-01-01 – 2022-09-30500000 USD20231108Open filing evidence
2022-01-01 – 2022-03-310 USD20230508Open filing evidence
2021-01-01 – 2021-12-31200000 USD20230227Open filing evidence
2021-07-01 – 2021-09-300 USD20221107Open filing evidence
2021-01-01 – 2021-09-300 USD20221107Open filing evidence
2021-01-01 – 2021-03-310 USD20210510Open filing evidence
2020-01-01 – 2020-12-31700000 USD20230227Open filing evidence

Complex GX And Biosimilars · Japan Australia And New Zealand Segment

Product Or Service · Statement Business Segments

Source dimensions srt:ProductOrServiceAxis=vtrs:ComplexGXAndBiosimilarsMember;us-gaap:StatementBusinessSegmentsAxis=vtrs:JapanAustraliaAndNewZealandSegmentMember
PeriodValueUnitFiledEvidence
2023-07-01 – 2023-09-308000000 USD20231108Open filing evidence
2023-01-01 – 2023-09-3020600000 USD20231108Open filing evidence
2022-01-01 – 2022-12-3144100000 USD20230227Open filing evidence
2022-07-01 – 2022-09-3010900000 USD20231108Open filing evidence
2022-01-01 – 2022-09-3033300000 USD20231108Open filing evidence
2022-01-01 – 2022-03-3110300000 USD20220509Open filing evidence
2021-01-01 – 2021-12-3146500000 USD20230227Open filing evidence
2021-07-01 – 2021-09-3013200000 USD20221107Open filing evidence
2021-01-01 – 2021-09-3031900000 USD20221107Open filing evidence
2021-01-01 – 2021-03-318900000 USD20220509Open filing evidence
2020-01-01 – 2020-12-3142800000 USD20230227Open filing evidence
2020-07-01 – 2020-09-308300000 USD20211108Open filing evidence
2020-01-01 – 2020-09-3025200000 USD20211108Open filing evidence

Generics · Developed Markets Segment

Product Or Service · Statement Business Segments

Source dimensions srt:ProductOrServiceAxis=vtrs:GenericsMember;us-gaap:StatementBusinessSegmentsAxis=vtrs:DevelopedMarketsSegmentMember
PeriodValueUnitFiledEvidence
2026-04-01 – 2026-06-301071400000 USD20260806Open filing evidence
2026-01-01 – 2026-06-302023200000 USD20260806Open filing evidence
2026-01-01 – 2026-03-31951800000 USD20260507Open filing evidence
2025-01-01 – 2025-12-313942800000 USD20260226Open filing evidence
2025-07-01 – 2025-09-301014300000 USD20251106Open filing evidence
2025-01-01 – 2025-09-302884100000 USD20251106Open filing evidence
2025-04-01 – 2025-06-30997900000 USD20260806Open filing evidence
2025-01-01 – 2025-06-301869800000 USD20260806Open filing evidence
2025-01-01 – 2025-03-31871900000 USD20260507Open filing evidence
2024-01-01 – 2024-12-314197800000 USD20260226Open filing evidence
2024-07-01 – 2024-09-301081100000 USD20251106Open filing evidence
2024-01-01 – 2024-09-303153100000 USD20251106Open filing evidence
2024-04-01 – 2024-06-301085400000 USD20250807Open filing evidence
2024-01-01 – 2024-06-302072000000 USD20250807Open filing evidence
2024-01-01 – 2024-03-31986600000 USD20250508Open filing evidence
2023-01-01 – 2023-12-314012900000 USD20260226Open filing evidence
2023-07-01 – 2023-09-301017200000 RestatedUSD20241107Open filing evidence
2023-01-01 – 2023-09-303009200000 RestatedUSD20241107Open filing evidence
2023-04-01 – 2023-06-301053600000 USD20240808Open filing evidence
2023-01-01 – 2023-06-301992000000 USD20240808Open filing evidence
2023-01-01 – 2023-03-31938400000 USD20240509Open filing evidence
2022-01-01 – 2022-12-314608500000 RestatedUSD20250227Open filing evidence
2022-07-01 – 2022-09-30808800000 USD20231108Open filing evidence
2022-01-01 – 2022-09-302468800000 USD20231108Open filing evidence
2022-01-01 – 2022-03-31813300000 USD20220509Open filing evidence
2021-01-01 – 2021-12-314669500000 RestatedUSD20240228Open filing evidence
2021-07-01 – 2021-09-30828100000 USD20211108Open filing evidence
2021-01-01 – 2021-09-302591000000 USD20211108Open filing evidence
2021-04-01 – 2021-06-30907000000 USD20210809Open filing evidence
2021-01-01 – 2021-06-301762900000 USD20210809Open filing evidence
2021-01-01 – 2021-03-31855900000 USD20220509Open filing evidence
2020-01-01 – 2020-12-313387600000 USD20230227Open filing evidence
2020-07-01 – 2020-09-30824200000 USD20211108Open filing evidence
2020-01-01 – 2020-09-302476100000 USD20211108Open filing evidence
2020-04-01 – 2020-06-30798600000 USD20210809Open filing evidence
2020-01-01 – 2020-06-301651900000 USD20210809Open filing evidence

Generics · Emerging Markets Segment

Product Or Service · Statement Business Segments

Source dimensions srt:ProductOrServiceAxis=vtrs:GenericsMember;us-gaap:StatementBusinessSegmentsAxis=vtrs:EmergingMarketsSegmentMember
PeriodValueUnitFiledEvidence
2026-04-01 – 2026-06-30101100000 USD20260806Open filing evidence
2026-01-01 – 2026-06-30189300000 USD20260806Open filing evidence
2026-01-01 – 2026-03-3188200000 USD20260507Open filing evidence
2025-01-01 – 2025-12-31536500000 USD20260226Open filing evidence
2025-07-01 – 2025-09-30146300000 USD20251106Open filing evidence
2025-01-01 – 2025-09-30402700000 USD20251106Open filing evidence
2025-04-01 – 2025-06-30139000000 USD20260806Open filing evidence
2025-01-01 – 2025-06-30256400000 USD20260806Open filing evidence
2025-01-01 – 2025-03-31117400000 USD20260507Open filing evidence
2024-01-01 – 2024-12-31682900000 USD20260226Open filing evidence
2024-07-01 – 2024-09-30137300000 USD20251106Open filing evidence
2024-01-01 – 2024-09-30542200000 USD20251106Open filing evidence
2024-04-01 – 2024-06-30182900000 USD20250807Open filing evidence
2024-01-01 – 2024-06-30404900000 USD20250807Open filing evidence
2024-01-01 – 2024-03-31222000000 USD20250508Open filing evidence
2023-01-01 – 2023-12-31925100000 USD20260226Open filing evidence
2023-07-01 – 2023-09-30232900000 RestatedUSD20241107Open filing evidence
2023-01-01 – 2023-09-30680700000 RestatedUSD20241107Open filing evidence
2023-04-01 – 2023-06-30241500000 USD20240808Open filing evidence
2023-01-01 – 2023-06-30447800000 USD20240808Open filing evidence
2022-01-01 – 2022-12-31999700000 USD20250227Open filing evidence
2022-07-01 – 2022-09-30235700000 USD20231108Open filing evidence
2022-01-01 – 2022-09-30735000000 USD20231108Open filing evidence
2022-04-01 – 2022-06-30247200000 USD20220808Open filing evidence
2022-01-01 – 2022-06-30499300000 USD20220808Open filing evidence
2021-01-01 – 2021-12-311467500000 USD20240228Open filing evidence
2021-07-01 – 2021-09-30364300000 USD20221107Open filing evidence
2021-01-01 – 2021-09-301088300000 USD20221107Open filing evidence
2021-04-01 – 2021-06-30423300000 USD20220808Open filing evidence
2021-01-01 – 2021-06-30724000000 USD20220808Open filing evidence
2020-01-01 – 2020-12-311361100000 USD20210301Open filing evidence
2020-07-01 – 2020-09-30372000000 USD20211108Open filing evidence
2020-01-01 – 2020-09-30976500000 USD20211108Open filing evidence
2020-01-01 – 2020-06-30604500000 USD20210809Open filing evidence

Generics · Greater China Segment

Product Or Service · Statement Business Segments

Source dimensions srt:ProductOrServiceAxis=vtrs:GenericsMember;us-gaap:StatementBusinessSegmentsAxis=vtrs:GreaterChinaSegmentMember
PeriodValueUnitFiledEvidence
2026-04-01 – 2026-06-303000000 USD20260806Open filing evidence
2026-01-01 – 2026-06-305900000 USD20260806Open filing evidence
2026-01-01 – 2026-03-312900000 USD20260507Open filing evidence
2025-01-01 – 2025-12-3110700000 USD20260226Open filing evidence
2025-07-01 – 2025-09-302900000 USD20251106Open filing evidence
2025-01-01 – 2025-09-308000000 USD20251106Open filing evidence
2025-04-01 – 2025-06-302400000 USD20260806Open filing evidence
2025-01-01 – 2025-06-305100000 USD20260806Open filing evidence
2025-01-01 – 2025-03-312700000 USD20260507Open filing evidence
2024-01-01 – 2024-12-319800000 USD20260226Open filing evidence
2024-07-01 – 2024-09-302400000 USD20251106Open filing evidence
2024-01-01 – 2024-09-307800000 USD20251106Open filing evidence
2024-04-01 – 2024-06-303300000 USD20250807Open filing evidence
2024-01-01 – 2024-06-305400000 USD20250807Open filing evidence
2024-01-01 – 2024-03-312100000 USD20250508Open filing evidence
2023-01-01 – 2023-12-318300000 USD20260226Open filing evidence
2023-07-01 – 2023-09-301900000 USD20241107Open filing evidence
2023-01-01 – 2023-09-305700000 USD20241107Open filing evidence
2023-04-01 – 2023-06-301600000 USD20240808Open filing evidence
2023-01-01 – 2023-06-303800000 USD20240808Open filing evidence
2023-01-01 – 2023-03-312200000 USD20240509Open filing evidence
2022-01-01 – 2022-12-3110500000 RestatedUSD20250227Open filing evidence
2022-07-01 – 2022-09-301900000 USD20231108Open filing evidence
2022-01-01 – 2022-09-307000000 USD20231108Open filing evidence
2022-04-01 – 2022-06-301700000 USD20220808Open filing evidence
2022-01-01 – 2022-03-313400000 USD20230508Open filing evidence
2021-01-01 – 2021-12-315000000 RestatedUSD20240228Open filing evidence
2021-07-01 – 2021-09-300 USD20221107Open filing evidence
2021-01-01 – 2021-09-302100000 USD20221107Open filing evidence
2021-04-01 – 2021-06-301100000 USD20220808Open filing evidence
2021-01-01 – 2021-06-302100000 USD20220808Open filing evidence
2021-01-01 – 2021-03-311000000 USD20210510Open filing evidence
2020-01-01 – 2020-12-315300000 USD20230227Open filing evidence
2020-07-01 – 2020-09-30900000 USD20211108Open filing evidence
2020-01-01 – 2020-09-301900000 USD20211108Open filing evidence

Generics · Japan Australia And New Zealand Segment

Product Or Service · Statement Business Segments

Source dimensions srt:ProductOrServiceAxis=vtrs:GenericsMember;us-gaap:StatementBusinessSegmentsAxis=vtrs:JapanAustraliaAndNewZealandSegmentMember
PeriodValueUnitFiledEvidence
2026-04-01 – 2026-06-30152000000 USD20260806Open filing evidence
2026-01-01 – 2026-06-30286300000 USD20260806Open filing evidence
2026-01-01 – 2026-03-31134300000 USD20260507Open filing evidence
2025-01-01 – 2025-12-31576400000 USD20260226Open filing evidence
2025-07-01 – 2025-09-30147200000 USD20251106Open filing evidence
2025-01-01 – 2025-09-30426700000 USD20251106Open filing evidence
2025-04-01 – 2025-06-30145200000 USD20260806Open filing evidence
2025-01-01 – 2025-06-30279500000 USD20260806Open filing evidence
2025-01-01 – 2025-03-31134300000 USD20260507Open filing evidence
2024-01-01 – 2024-12-31602000000 USD20260226Open filing evidence
2024-07-01 – 2024-09-30155000000 USD20251106Open filing evidence
2024-01-01 – 2024-09-30439900000 USD20251106Open filing evidence
2024-04-01 – 2024-06-30151200000 USD20250807Open filing evidence
2024-01-01 – 2024-06-30284900000 USD20250807Open filing evidence
2024-01-01 – 2024-03-31133700000 USD20250508Open filing evidence
2023-01-01 – 2023-12-31641600000 USD20260226Open filing evidence
2023-07-01 – 2023-09-30148800000 RestatedUSD20241107Open filing evidence
2023-01-01 – 2023-09-30468800000 RestatedUSD20241107Open filing evidence
2023-04-01 – 2023-06-30168100000 USD20240808Open filing evidence
2023-01-01 – 2023-06-30320000000 USD20240808Open filing evidence
2022-01-01 – 2022-12-31709800000 RestatedUSD20250227Open filing evidence
2022-07-01 – 2022-09-30160500000 USD20231108Open filing evidence
2022-01-01 – 2022-09-30496900000 USD20231108Open filing evidence
2022-04-01 – 2022-06-30171900000 USD20220808Open filing evidence
2022-01-01 – 2022-06-30336400000 USD20220808Open filing evidence
2022-01-01 – 2022-03-31164500000 USD20220509Open filing evidence
2021-01-01 – 2021-12-31783800000 USD20230227Open filing evidence
2021-07-01 – 2021-09-30193000000 USD20221107Open filing evidence
2021-01-01 – 2021-09-30577800000 USD20221107Open filing evidence
2021-04-01 – 2021-06-30195800000 USD20220808Open filing evidence
2021-01-01 – 2021-06-30384800000 USD20220808Open filing evidence
2021-01-01 – 2021-03-31189000000 USD20220509Open filing evidence
2020-01-01 – 2020-12-31535500000 USD20230227Open filing evidence
2020-07-01 – 2020-09-30157300000 USD20211108Open filing evidence
2020-01-01 – 2020-09-30445100000 USD20211108Open filing evidence

Developed Markets Segment

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=vtrs:DevelopedMarketsSegmentMember
PeriodValueUnitFiledEvidence
2026-07-01 – 2026-09-302224800000 USD20261105Open filing evidence
2026-01-01 – 2026-09-306453800000 USD20261105Open filing evidence
2026-04-01 – 2026-06-302203000000 USD20260806Open filing evidence
2026-01-01 – 2026-06-304229000000 USD20260806Open filing evidence
2026-01-01 – 2026-03-312026000000 USD20260507Open filing evidence
2025-07-01 – 2025-09-302265600000 USD20261105Open filing evidence
2025-01-01 – 2025-09-306293800000 USD20261105Open filing evidence
2025-04-01 – 2025-06-302129600000 USD20260806Open filing evidence
2025-01-01 – 2025-06-304028200000 USD20260806Open filing evidence
2025-01-01 – 2025-03-311898600000 USD20260507Open filing evidence
2024-07-01 – 2024-09-302308200000 USD20251106Open filing evidence
2024-01-01 – 2024-09-306805900000 USD20251106Open filing evidence
2024-04-01 – 2024-06-302325100000 USD20250807Open filing evidence
2024-01-01 – 2024-06-304497700000 USD20250807Open filing evidence
2024-01-01 – 2024-03-312172600000 USD20250508Open filing evidence

Developed Markets Segment · Operating Segments

Statement Business Segments · Consolidation Items

Source dimensions us-gaap:StatementBusinessSegmentsAxis=vtrs:DevelopedMarketsSegmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember
PeriodValueUnitFiledEvidence
2026-07-01 – 2026-09-302215900000 USD20261105Open filing evidence
2026-01-01 – 2026-09-306430400000 USD20261105Open filing evidence
2025-07-01 – 2025-09-302255600000 USD20261105Open filing evidence
2025-01-01 – 2025-09-306266600000 USD20261105Open filing evidence
2023-04-01 – 2023-06-302353800000 USD20230807Open filing evidence
2023-01-01 – 2023-06-304524200000 USD20230807Open filing evidence
2022-07-01 – 2022-09-302431500000 USD20221107Open filing evidence
2022-01-01 – 2022-09-307386700000 USD20221107Open filing evidence
2022-04-01 – 2022-06-302479100000 USD20230807Open filing evidence
2022-01-01 – 2022-06-304955200000 USD20230807Open filing evidence
2021-07-01 – 2021-09-302655900000 USD20221107Open filing evidence
2021-01-01 – 2021-09-307867900000 USD20221107Open filing evidence
2020-07-01 – 2020-09-302163200000 USD20211108Open filing evidence
2020-01-01 – 2020-09-306132300000 USD20211108Open filing evidence

Developed Markets Segment · Brands

Statement Business Segments · Product Or Service

Source dimensions us-gaap:StatementBusinessSegmentsAxis=vtrs:DevelopedMarketsSegmentMember;srt:ProductOrServiceAxis=vtrs:BrandsMember
PeriodValueUnitFiledEvidence
2026-07-01 – 2026-09-301184600000 USD20261105Open filing evidence
2026-01-01 – 2026-09-303375900000 USD20261105Open filing evidence
2025-07-01 – 2025-09-301241300000 USD20261105Open filing evidence
2025-01-01 – 2025-09-303382500000 USD20261105Open filing evidence
2023-07-01 – 2023-09-301391300000 USD20231108Open filing evidence
2023-01-01 – 2023-09-303923500000 USD20231108Open filing evidence
2023-01-01 – 2023-03-311232000000 USD20230508Open filing evidence
2022-07-01 – 2022-09-301327700000 USD20231108Open filing evidence
2022-01-01 – 2022-09-303931800000 USD20231108Open filing evidence
2022-01-01 – 2022-03-311298700000 USD20230508Open filing evidence
2021-01-01 – 2021-12-315759200000 USD20220228Open filing evidence
2021-07-01 – 2021-09-301522700000 USD20221107Open filing evidence
2021-01-01 – 2021-09-304350500000 USD20221107Open filing evidence
2021-01-01 – 2021-03-311403700000 USD20220509Open filing evidence
2020-01-01 – 2020-12-313920700000 USD20220228Open filing evidence
2020-07-01 – 2020-09-301013200000 USD20211108Open filing evidence
2020-01-01 – 2020-09-302760200000 USD20211108Open filing evidence

Developed Markets Segment · Complex GX And Biosimilars

Statement Business Segments · Product Or Service

Source dimensions us-gaap:StatementBusinessSegmentsAxis=vtrs:DevelopedMarketsSegmentMember;srt:ProductOrServiceAxis=vtrs:ComplexGXAndBiosimilarsMember
PeriodValueUnitFiledEvidence
2023-04-01 – 2023-06-30132700000 USD20230807Open filing evidence
2023-01-01 – 2023-06-30262600000 USD20230807Open filing evidence
2022-07-01 – 2022-09-30295000000 USD20221107Open filing evidence
2022-01-01 – 2022-09-30986100000 USD20221107Open filing evidence
2022-04-01 – 2022-06-30327000000 USD20230807Open filing evidence
2022-01-01 – 2022-06-30691100000 USD20230807Open filing evidence
2021-07-01 – 2021-09-30305100000 USD20221107Open filing evidence
2021-01-01 – 2021-09-30926400000 USD20221107Open filing evidence
2021-04-01 – 2021-06-30309300000 USD20220808Open filing evidence
2021-01-01 – 2021-06-30621300000 USD20220808Open filing evidence

Developed Markets Segment · Generics

Statement Business Segments · Product Or Service

Source dimensions us-gaap:StatementBusinessSegmentsAxis=vtrs:DevelopedMarketsSegmentMember;srt:ProductOrServiceAxis=vtrs:GenericsMember
PeriodValueUnitFiledEvidence
2026-07-01 – 2026-09-301031300000 USD20261105Open filing evidence
2026-01-01 – 2026-09-303054500000 USD20261105Open filing evidence
2025-07-01 – 2025-09-301014300000 USD20261105Open filing evidence
2025-01-01 – 2025-09-302884100000 USD20261105Open filing evidence
2023-04-01 – 2023-06-30920900000 USD20230807Open filing evidence
2023-01-01 – 2023-06-301729400000 USD20230807Open filing evidence
2023-01-01 – 2023-03-31808500000 USD20230508Open filing evidence
2022-07-01 – 2022-09-30808800000 USD20221107Open filing evidence
2022-01-01 – 2022-09-302468800000 USD20221107Open filing evidence
2022-04-01 – 2022-06-30846700000 USD20230807Open filing evidence
2022-01-01 – 2022-06-301660000000 USD20230807Open filing evidence
2022-01-01 – 2022-03-31813300000 USD20230508Open filing evidence
2021-07-01 – 2021-09-30828100000 USD20221107Open filing evidence
2021-01-01 – 2021-09-302591000000 USD20221107Open filing evidence
2021-04-01 – 2021-06-30907000000 USD20220808Open filing evidence
2021-01-01 – 2021-06-301762900000 USD20220808Open filing evidence
2020-01-01 – 2020-12-313387600000 USD20210301Open filing evidence

Emerging Markets Segment

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=vtrs:EmergingMarketsSegmentMember
PeriodValueUnitFiledEvidence
2026-07-01 – 2026-09-30531100000 USD20261105Open filing evidence
2026-01-01 – 2026-09-301612300000 USD20261105Open filing evidence
2026-04-01 – 2026-06-30543800000 USD20260806Open filing evidence
2026-01-01 – 2026-06-301081200000 USD20260806Open filing evidence
2026-01-01 – 2026-03-31537400000 USD20260507Open filing evidence
2025-07-01 – 2025-09-30571800000 USD20261105Open filing evidence
2025-01-01 – 2025-09-301651800000 USD20261105Open filing evidence
2025-04-01 – 2025-06-30556900000 USD20260806Open filing evidence
2025-01-01 – 2025-06-301080000000 USD20260806Open filing evidence
2025-01-01 – 2025-03-31523100000 USD20260507Open filing evidence
2024-07-01 – 2024-09-30535300000 USD20251106Open filing evidence
2024-01-01 – 2024-09-301746400000 USD20251106Open filing evidence
2024-04-01 – 2024-06-30582300000 USD20250807Open filing evidence
2024-01-01 – 2024-06-301211100000 USD20250807Open filing evidence
2024-01-01 – 2024-03-31628800000 USD20250508Open filing evidence

Emerging Markets Segment · Operating Segments

Statement Business Segments · Consolidation Items

Source dimensions us-gaap:StatementBusinessSegmentsAxis=vtrs:EmergingMarketsSegmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember
PeriodValueUnitFiledEvidence
2026-07-01 – 2026-09-30529100000 USD20261105Open filing evidence
2026-01-01 – 2026-09-301606800000 USD20261105Open filing evidence
2025-07-01 – 2025-09-30570400000 USD20261105Open filing evidence
2025-01-01 – 2025-09-301645400000 USD20261105Open filing evidence
2024-01-01 – 2024-03-31626400000 USD20240509Open filing evidence
2023-04-01 – 2023-06-30648100000 USD20230807Open filing evidence
2023-01-01 – 2023-06-301290000000 USD20230807Open filing evidence
2023-01-01 – 2023-03-31641900000 USD20240509Open filing evidence
2022-01-01 – 2022-12-312615600000 USD20230227Open filing evidence
2022-04-01 – 2022-06-30650900000 USD20230807Open filing evidence
2022-01-01 – 2022-06-301356100000 USD20230807Open filing evidence
2022-01-01 – 2022-03-31705200000 USD20220509Open filing evidence
2021-01-01 – 2021-12-313144700000 USD20230227Open filing evidence
2021-07-01 – 2021-09-30792500000 USD20211108Open filing evidence
2021-01-01 – 2021-09-302417200000 USD20211108Open filing evidence
2021-04-01 – 2021-06-30870000000 USD20210809Open filing evidence
2021-01-01 – 2021-06-301624700000 USD20210809Open filing evidence
2021-01-01 – 2021-03-31754700000 USD20220509Open filing evidence
2020-01-01 – 2020-12-311853800000 USD20230227Open filing evidence
2020-07-01 – 2020-09-30471000000 USD20211108Open filing evidence
2020-01-01 – 2020-09-301224800000 USD20211108Open filing evidence

Emerging Markets Segment · Brands

Statement Business Segments · Product Or Service

Source dimensions us-gaap:StatementBusinessSegmentsAxis=vtrs:EmergingMarketsSegmentMember;srt:ProductOrServiceAxis=vtrs:BrandsMember
PeriodValueUnitFiledEvidence
2026-07-01 – 2026-09-30436200000 USD20261105Open filing evidence
2026-01-01 – 2026-09-301324600000 USD20261105Open filing evidence
2025-07-01 – 2025-09-30424100000 USD20261105Open filing evidence
2025-01-01 – 2025-09-301242700000 USD20261105Open filing evidence
2024-01-01 – 2024-03-31404400000 USD20240509Open filing evidence
2023-07-01 – 2023-09-30409600000 USD20231108Open filing evidence
2023-01-01 – 2023-09-301251800000 USD20231108Open filing evidence
2023-01-01 – 2023-03-31435600000 USD20240509Open filing evidence
2022-07-01 – 2022-09-30429100000 USD20231108Open filing evidence
2022-01-01 – 2022-09-301254100000 USD20231108Open filing evidence
2022-01-01 – 2022-03-31436700000 USD20230508Open filing evidence
2021-01-01 – 2021-12-311677200000 USD20220228Open filing evidence
2021-07-01 – 2021-09-30414500000 USD20211108Open filing evidence
2021-01-01 – 2021-09-301293500000 USD20211108Open filing evidence
2021-01-01 – 2021-03-31446000000 USD20220509Open filing evidence
2020-01-01 – 2020-12-31443300000 USD20220228Open filing evidence
2020-07-01 – 2020-09-3080900000 USD20211108Open filing evidence
2020-01-01 – 2020-09-30213000000 USD20211108Open filing evidence

Emerging Markets Segment · Complex GX And Biosimilars

Statement Business Segments · Product Or Service

Source dimensions us-gaap:StatementBusinessSegmentsAxis=vtrs:EmergingMarketsSegmentMember;srt:ProductOrServiceAxis=vtrs:ComplexGXAndBiosimilarsMember
PeriodValueUnitFiledEvidence
2023-04-01 – 2023-06-300 USD20230807Open filing evidence
2023-01-01 – 2023-06-30100000 USD20230807Open filing evidence
2023-01-01 – 2023-03-31100000 USD20230508Open filing evidence
2022-04-01 – 2022-06-3015400000 USD20230807Open filing evidence
2022-01-01 – 2022-06-3031800000 USD20230807Open filing evidence
2022-01-01 – 2022-03-3116400000 USD20230508Open filing evidence
2021-07-01 – 2021-09-3013700000 USD20211108Open filing evidence
2021-01-01 – 2021-09-3035400000 USD20211108Open filing evidence
2021-04-01 – 2021-06-3013700000 USD20220808Open filing evidence
2021-01-01 – 2021-06-3021700000 USD20220808Open filing evidence
2021-01-01 – 2021-03-318000000 USD20220509Open filing evidence
2020-07-01 – 2020-09-3018100000 USD20211108Open filing evidence
2020-01-01 – 2020-09-3035300000 USD20211108Open filing evidence

Emerging Markets Segment · Generics

Statement Business Segments · Product Or Service

Source dimensions us-gaap:StatementBusinessSegmentsAxis=vtrs:EmergingMarketsSegmentMember;srt:ProductOrServiceAxis=vtrs:GenericsMember
PeriodValueUnitFiledEvidence
2026-07-01 – 2026-09-3092900000 USD20261105Open filing evidence
2026-01-01 – 2026-09-30282200000 USD20261105Open filing evidence
2025-07-01 – 2025-09-30146300000 USD20261105Open filing evidence
2025-01-01 – 2025-09-30402700000 USD20261105Open filing evidence
2024-01-01 – 2024-03-31222000000 USD20240509Open filing evidence
2023-04-01 – 2023-06-30241500000 USD20230807Open filing evidence
2023-01-01 – 2023-06-30447700000 USD20230807Open filing evidence
2023-01-01 – 2023-03-31206300000 RestatedUSD20240509Open filing evidence
2022-01-01 – 2022-12-31949000000 USD20230227Open filing evidence
2022-04-01 – 2022-06-30247200000 USD20230807Open filing evidence
2022-01-01 – 2022-06-30499300000 USD20230807Open filing evidence
2022-01-01 – 2022-03-31252100000 USD20230508Open filing evidence
2021-01-01 – 2021-12-311413700000 USD20230227Open filing evidence
2021-01-01 – 2021-03-31300700000 USD20220509Open filing evidence
2020-01-01 – 2020-12-311361100000 USD20230227Open filing evidence

Greater China Segment

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=vtrs:GreaterChinaSegmentMember
PeriodValueUnitFiledEvidence
2026-07-01 – 2026-09-30702600000 USD20261105Open filing evidence
2026-01-01 – 2026-09-302096500000 USD20261105Open filing evidence
2026-04-01 – 2026-06-30713800000 USD20260806Open filing evidence
2026-01-01 – 2026-06-301393900000 USD20260806Open filing evidence
2026-01-01 – 2026-03-31680100000 USD20260507Open filing evidence
2025-07-01 – 2025-09-30615200000 USD20261105Open filing evidence
2025-01-01 – 2025-09-301759600000 USD20261105Open filing evidence
2025-04-01 – 2025-06-30588900000 USD20260806Open filing evidence
2025-01-01 – 2025-06-301144400000 USD20260806Open filing evidence
2025-01-01 – 2025-03-31555500000 USD20260507Open filing evidence
2024-07-01 – 2024-09-30562200000 USD20251106Open filing evidence
2024-01-01 – 2024-09-301645500000 USD20251106Open filing evidence
2024-04-01 – 2024-06-30539400000 USD20250807Open filing evidence
2024-01-01 – 2024-06-301083300000 USD20250807Open filing evidence
2024-01-01 – 2024-03-31543900000 USD20250508Open filing evidence

Greater China Segment · Operating Segments

Statement Business Segments · Consolidation Items

Source dimensions us-gaap:StatementBusinessSegmentsAxis=vtrs:GreaterChinaSegmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember
PeriodValueUnitFiledEvidence
2026-07-01 – 2026-09-30702600000 USD20261105Open filing evidence
2026-01-01 – 2026-09-302096500000 USD20261105Open filing evidence
2025-07-01 – 2025-09-30615200000 USD20261105Open filing evidence
2025-01-01 – 2025-09-301759600000 USD20261105Open filing evidence
2023-04-01 – 2023-06-30532100000 USD20230807Open filing evidence
2023-01-01 – 2023-06-301096700000 USD20230807Open filing evidence
2022-04-01 – 2022-06-30548300000 USD20230807Open filing evidence
2022-01-01 – 2022-06-301121400000 USD20230807Open filing evidence
2022-01-01 – 2022-03-31573100000 USD20220509Open filing evidence
2021-07-01 – 2021-09-30566800000 USD20211108Open filing evidence
2021-01-01 – 2021-09-301709000000 USD20211108Open filing evidence
2021-04-01 – 2021-06-30550300000 USD20210809Open filing evidence
2021-01-01 – 2021-06-301142200000 USD20210809Open filing evidence
2021-01-01 – 2021-03-31591900000 USD20220509Open filing evidence
2020-01-01 – 2020-12-31259900000 USD20210301Open filing evidence
2020-07-01 – 2020-09-3031500000 USD20211108Open filing evidence
2020-01-01 – 2020-09-3069300000 USD20211108Open filing evidence

Greater China Segment · Brands

Statement Business Segments · Product Or Service

Source dimensions us-gaap:StatementBusinessSegmentsAxis=vtrs:GreaterChinaSegmentMember;srt:ProductOrServiceAxis=vtrs:BrandsMember
PeriodValueUnitFiledEvidence
2026-07-01 – 2026-09-30697100000 USD20261105Open filing evidence
2026-01-01 – 2026-09-302085100000 USD20261105Open filing evidence
2025-07-01 – 2025-09-30612300000 USD20261105Open filing evidence
2025-01-01 – 2025-09-301751600000 USD20261105Open filing evidence
2023-01-01 – 2023-12-312152100000 USD20240228Open filing evidence
2022-01-01 – 2022-12-312190700000 USD20240228Open filing evidence
2022-07-01 – 2022-09-30571900000 USD20221107Open filing evidence
2022-01-01 – 2022-09-301687900000 USD20221107Open filing evidence
2022-01-01 – 2022-03-31569700000 USD20220509Open filing evidence
2021-01-01 – 2021-12-312207800000 USD20240228Open filing evidence
2021-07-01 – 2021-09-30566800000 USD20221107Open filing evidence
2021-01-01 – 2021-09-301706900000 USD20221107Open filing evidence
2021-01-01 – 2021-03-31590900000 USD20220509Open filing evidence
2020-01-01 – 2020-12-31253900000 USD20220228Open filing evidence
2020-07-01 – 2020-09-3030500000 USD20211108Open filing evidence
2020-01-01 – 2020-09-3067200000 USD20211108Open filing evidence

Greater China Segment · Complex GX And Biosimilars

Statement Business Segments · Product Or Service

Source dimensions us-gaap:StatementBusinessSegmentsAxis=vtrs:GreaterChinaSegmentMember;srt:ProductOrServiceAxis=vtrs:ComplexGXAndBiosimilarsMember
PeriodValueUnitFiledEvidence
2023-04-01 – 2023-06-300 USD20230807Open filing evidence
2023-01-01 – 2023-06-300 USD20230807Open filing evidence
2022-04-01 – 2022-06-30300000 USD20230807Open filing evidence
2022-01-01 – 2022-06-30300000 USD20230807Open filing evidence
2022-01-01 – 2022-03-310 USD20220509Open filing evidence
2021-07-01 – 2021-09-300 USD20211108Open filing evidence
2021-01-01 – 2021-09-300 USD20211108Open filing evidence
2021-04-01 – 2021-06-300 USD20220808Open filing evidence
2021-01-01 – 2021-06-300 USD20220808Open filing evidence
2021-01-01 – 2021-03-310 USD20220509Open filing evidence
2020-07-01 – 2020-09-30100000 USD20211108Open filing evidence
2020-01-01 – 2020-09-30200000 USD20211108Open filing evidence

Greater China Segment · Generics

Statement Business Segments · Product Or Service

Source dimensions us-gaap:StatementBusinessSegmentsAxis=vtrs:GreaterChinaSegmentMember;srt:ProductOrServiceAxis=vtrs:GenericsMember
PeriodValueUnitFiledEvidence
2026-07-01 – 2026-09-305500000 USD20261105Open filing evidence
2026-01-01 – 2026-09-3011400000 USD20261105Open filing evidence
2025-07-01 – 2025-09-302900000 USD20261105Open filing evidence
2025-01-01 – 2025-09-308000000 USD20261105Open filing evidence
2023-04-01 – 2023-06-301600000 USD20230807Open filing evidence
2023-01-01 – 2023-06-303800000 USD20230807Open filing evidence
2022-04-01 – 2022-06-301700000 USD20230807Open filing evidence
2022-01-01 – 2022-06-305100000 USD20230807Open filing evidence
2022-01-01 – 2022-03-313400000 USD20220509Open filing evidence
2021-01-01 – 2021-03-311000000 USD20220509Open filing evidence
2020-01-01 – 2020-12-315300000 USD20210301Open filing evidence

Japan Australia And New Zealand Segment

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=vtrs:JapanAustraliaAndNewZealandSegmentMember
PeriodValueUnitFiledEvidence
2026-07-01 – 2026-09-30291000000 USD20261105Open filing evidence
2026-01-01 – 2026-09-30860700000 USD20261105Open filing evidence
2026-04-01 – 2026-06-30296200000 USD20260806Open filing evidence
2026-01-01 – 2026-06-30569700000 USD20260806Open filing evidence
2026-01-01 – 2026-03-31273500000 USD20260507Open filing evidence
2025-07-01 – 2025-09-30307300000 USD20261105Open filing evidence
2025-01-01 – 2025-09-30891100000 USD20261105Open filing evidence
2025-04-01 – 2025-06-30306700000 USD20260806Open filing evidence
2025-01-01 – 2025-06-30583800000 USD20260806Open filing evidence
2025-01-01 – 2025-03-31277100000 USD20260507Open filing evidence
2024-07-01 – 2024-09-30345500000 USD20251106Open filing evidence
2024-01-01 – 2024-09-301013400000 USD20251106Open filing evidence
2024-04-01 – 2024-06-30349800000 USD20250807Open filing evidence
2024-01-01 – 2024-06-30667900000 USD20250807Open filing evidence
2024-01-01 – 2024-03-31318100000 USD20250508Open filing evidence

Japan Australia And New Zealand Segment · Operating Segments

Statement Business Segments · Consolidation Items

Source dimensions us-gaap:StatementBusinessSegmentsAxis=vtrs:JapanAustraliaAndNewZealandSegmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember
PeriodValueUnitFiledEvidence
2026-07-01 – 2026-09-30287100000 USD20261105Open filing evidence
2026-01-01 – 2026-09-30856600000 USD20261105Open filing evidence
2025-07-01 – 2025-09-30306300000 USD20261105Open filing evidence
2025-01-01 – 2025-09-30888100000 USD20261105Open filing evidence
2024-01-01 – 2024-03-31317800000 USD20240509Open filing evidence
2023-01-01 – 2023-12-311424500000 USD20240228Open filing evidence
2023-04-01 – 2023-06-30375500000 USD20230807Open filing evidence
2023-01-01 – 2023-06-30717700000 USD20230807Open filing evidence
2023-01-01 – 2023-03-31342200000 USD20240509Open filing evidence
2022-01-01 – 2022-12-311632400000 USD20240228Open filing evidence
2022-04-01 – 2022-06-30427100000 USD20230807Open filing evidence
2022-01-01 – 2022-06-30850900000 USD20230807Open filing evidence
2022-01-01 – 2022-03-31423800000 USD20230508Open filing evidence
2021-01-01 – 2021-12-312027400000 USD20240228Open filing evidence
2021-07-01 – 2021-09-30505300000 USD20211108Open filing evidence
2021-01-01 – 2021-09-301488200000 USD20211108Open filing evidence
2021-04-01 – 2021-06-30501000000 USD20210809Open filing evidence
2021-01-01 – 2021-06-30982900000 USD20210809Open filing evidence
2020-07-01 – 2020-09-30282400000 USD20211108Open filing evidence
2020-01-01 – 2020-09-30805800000 USD20211108Open filing evidence

Japan Australia And New Zealand Segment · Brands

Statement Business Segments · Product Or Service

Source dimensions us-gaap:StatementBusinessSegmentsAxis=vtrs:JapanAustraliaAndNewZealandSegmentMember;srt:ProductOrServiceAxis=vtrs:BrandsMember
PeriodValueUnitFiledEvidence
2026-07-01 – 2026-09-30143500000 USD20261105Open filing evidence
2026-01-01 – 2026-09-30426700000 USD20261105Open filing evidence
2025-07-01 – 2025-09-30159100000 USD20261105Open filing evidence
2025-01-01 – 2025-09-30461400000 USD20261105Open filing evidence
2024-01-01 – 2024-03-31184100000 USD20240509Open filing evidence
2023-01-01 – 2023-12-31782900000 USD20240228Open filing evidence
2023-07-01 – 2023-09-30185700000 USD20231108Open filing evidence
2023-01-01 – 2023-09-30583400000 USD20231108Open filing evidence
2023-01-01 – 2023-03-31190300000 USD20240509Open filing evidence
2022-01-01 – 2022-12-31922600000 USD20240228Open filing evidence
2022-07-01 – 2022-09-30211600000 USD20231108Open filing evidence
2022-01-01 – 2022-09-30703700000 USD20231108Open filing evidence
2022-01-01 – 2022-03-31249000000 USD20230508Open filing evidence
2021-01-01 – 2021-12-311197100000 USD20240228Open filing evidence
2021-07-01 – 2021-09-30299100000 USD20221107Open filing evidence
2021-01-01 – 2021-09-30878500000 USD20221107Open filing evidence
2020-07-01 – 2020-09-30116800000 USD20211108Open filing evidence
2020-01-01 – 2020-09-30335500000 USD20211108Open filing evidence

Japan Australia And New Zealand Segment · Complex GX And Biosimilars

Statement Business Segments · Product Or Service

Source dimensions us-gaap:StatementBusinessSegmentsAxis=vtrs:JapanAustraliaAndNewZealandSegmentMember;srt:ProductOrServiceAxis=vtrs:ComplexGXAndBiosimilarsMember
PeriodValueUnitFiledEvidence
2023-04-01 – 2023-06-306500000 USD20230807Open filing evidence
2023-01-01 – 2023-06-3012600000 USD20230807Open filing evidence
2023-01-01 – 2023-03-316100000 USD20230508Open filing evidence
2022-04-01 – 2022-06-3012100000 USD20230807Open filing evidence
2022-01-01 – 2022-06-3022400000 USD20230807Open filing evidence
2022-01-01 – 2022-03-3110300000 USD20230508Open filing evidence
2021-04-01 – 2021-06-309800000 USD20220808Open filing evidence
2021-01-01 – 2021-06-3018700000 USD20220808Open filing evidence
2021-01-01 – 2021-03-318900000 USD20210510Open filing evidence

Japan Australia And New Zealand Segment · Generics

Statement Business Segments · Product Or Service

Source dimensions us-gaap:StatementBusinessSegmentsAxis=vtrs:JapanAustraliaAndNewZealandSegmentMember;srt:ProductOrServiceAxis=vtrs:GenericsMember
PeriodValueUnitFiledEvidence
2026-07-01 – 2026-09-30143600000 USD20261105Open filing evidence
2026-01-01 – 2026-09-30429900000 USD20261105Open filing evidence
2025-07-01 – 2025-09-30147200000 USD20261105Open filing evidence
2025-01-01 – 2025-09-30426700000 USD20261105Open filing evidence
2024-01-01 – 2024-03-31133700000 USD20240509Open filing evidence
2023-01-01 – 2023-12-31641600000 USD20240228Open filing evidence
2023-04-01 – 2023-06-30161600000 USD20230807Open filing evidence
2023-01-01 – 2023-06-30307400000 USD20230807Open filing evidence
2023-01-01 – 2023-03-31151900000 RestatedUSD20240509Open filing evidence
2022-01-01 – 2022-12-31709800000 USD20240228Open filing evidence
2022-04-01 – 2022-06-30171900000 USD20230807Open filing evidence
2022-01-01 – 2022-06-30336400000 USD20230807Open filing evidence
2022-01-01 – 2022-03-31164500000 USD20230508Open filing evidence
2021-01-01 – 2021-12-31830300000 USD20240228Open filing evidence